BetterLife Resumes Trading Following CSE Merger Ratification with Altum Pharmaceuticals
Vancouver, Sept. 01, 2020 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / […]
Ansys CFO to Present at CITI 2020 Global Technology Conference
PITTSBURGH, Sept. 01, 2020 (GLOBE NEWSWIRE) — ANSYS, Inc. (NASDAQ: ANSS), announced today that Maria Shields, Senior Vice President, CFO […]
TSX News -
MediPharm Labs Enters Denmark Medical Cannabis Market, Secures New White-Label Supply Customers
TORONTO, Sept. 01, 2020 (GLOBE NEWSWIRE) — MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE:MLZ) (“MediPharm Labs” or the “Company”) […]
Plus Therapeutics, Inc. receives FDA Orphan Drug Designation for its Novel Glioblastoma Treatment
AUSTIN, Texas, Sept. 01, 2020 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), today announced that the U.S. Food […]
Zentalis Pharmaceuticals Appoints Alexis Pinto as Chief Legal Officer
NEW YORK and SAN DIEGO, Sept. 01, 2020 (GLOBE NEWSWIRE) — Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company […]
Athenex Announces FDA Acceptance for Filing of U.S. NDA for Oral Paclitaxel and Encequidar in Metastatic Breast Cancer with Priority Review
FDA grants Priority Review and sets PDUFA target action date of February 28, 2021FDA indicated that it is not currently […]
Orchard Therapeutics Announces Additional Interim Results from Proof-of-Concept Study of OTL-203 for MPS-I
Data on all eight patients demonstrate sustained engraftment and supranormal IDUA enzyme expressionTranslation of metabolic correction to clinical outcomes in […]
TSX News -
goeasy Ltd. Announces Appointment of Farhan Ali Khan as Senior Vice-President of Corporate Development and Investor Relations
MISSISSAUGA, Ontario, Sept. 01, 2020 (GLOBE NEWSWIRE) — goeasy Ltd. (TSX: GSY), (“goeasy” or the “Company”), a leading full-service provider of […]
TSX News -
Aleafia Health Subsidiary Secures Regulatory Approvals for Cannabis Sales in Germany
TORONTO, Sept. 01, 2020 (GLOBE NEWSWIRE) — Aleafia Health Inc.’s (TSX: AH, OTC: ALEAF) (“Aleafia Health” or the “Company”) indirect […]
TSX News -
RE-RELEASE – Troilus’ Preliminary Economic Assessment Delivers an After-Tax NPV5% of US$1,156 Million With a 38.3% IRR at a Spot Price of US$1950/oz Gold and an NPV5% of US$576 Million and 22.9% IRR at Base Case US$1475/oz Gold
TORONTO, Sept. 01, 2020 (GLOBE NEWSWIRE) — Troilus Gold Corp. (TSX: TLG; OTCQB: CHXMF) (“Troilus” or the “Company”) is pleased […]
